ProofPilot
From Wikipedia, the free encyclopedia
 | |
| Company type | Clinical trial platform |
|---|---|
| Industry | |
| Headquarters | |
Key people | Chris Venezia |
| Products | ProofPilot |
| Website | www |
ProofPilot is an American Internet company with offices in New York City. Its namesake product is a digital protocol automation platform that aims to eliminate guesswork and protocol deviations[how?] in clinical settings. Chris Venezia joined as the Chief Executive Officer in 2022.[1]
ProofPilot grew out of the consulting firm Cyclogram in 2013. Matthew Amsden started Cyclogram in 2005.[2]
Early versions of the platform supported studies in the United States, Brazil and Peru.[1] ProofPilot participated in the BluePrint Health Incubator program in the winter of 2014.[3]
Amsden has talked about the challenges of creating a digital health startup and the cultural disconnect between buyers and venture-capital-backed startups. He says that adhering to the typical venture-backed startup "rulebook" almost killed ProofPilot.[4] The company relaunched the product in late 2017 after not taking on customers for over two years.[5]
Model
The ProofPilot platform is split in three parts. The first allows users the ability to design research studies. The design process (and resulting participant experience) is based on a concept called micro-interactions.[6] Non-experienced study designers can use study templates and fill in the blanks to create a study.[7] The second is the participant experience. After study designers launch the study, it goes through an automatic external regulatory review by Veritas IRB in Montreal, Quebec, Canada.[8] Then, participants begin to engage in the study via mobile phones and desktop computers. ProofPilot has publicly stated it has deprioritized development of a native iOS and Android application because Progressive web apps provide a better user experience.[9] The system also provides reporting of findings.